GGrantIndex
← Leaderboards

Pawel R Kiela

University Of Arizona

$7,064,974
Attributed
$11,284,123
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,284,123 · 7

By mechanism

R01$9,809,236 · 5
P42$1,474,887 · 2

Top collaborators

Most similar at University Of Arizona

Same institution · by research overlap

Others in their field

Top investigators on “Affect

Research focus

AffectColitisInflammatory Bowel DiseasesChronicInflammatoryInflammationMediatingSymptomsResponseEpithelial CellsIntestinesImmuneIn VivoPathogenesisMucous MembraneMicrobialGut MicrobiotaS DiseasePredispositionGenesImmune ResponseMicrobiotaPreventFuture

Grant awards (35)

PARP1 and PARylation as novel effectors of gut inflammation$626,295
R01 · FY2025 · DK · contact PI
PARP1 and PARylation as novel effectors of gut inflammation$66,415
R01 · FY2025 · DK · contact PI
PARP1 and PARylation as novel effectors of gut inflammation$601,244
R01 · FY2024 · DK · contact PI
Microbial Contributions to Arsenic Transformation in the Gut$296,130
P42 · FY2024 · ES · contact PI
Diversity Supplement to PARP1 and PARylation as novel effectors of gut inflammation$38,812
R01 · FY2024 · DK · contact PI
PARP1 and PARylation as novel effectors of gut inflammation$615,535
R01 · FY2023 · DK · contact PI
Intestinal lysozyme controls mucosal immune response to microbiota$358,541
R01 · FY2023 · DK
Microbial Contributions to Arsenic Transformation in the Gut$287,556
P42 · FY2023 · ES · contact PI
Intestinal lysozyme controls mucosal immune response to microbiota$358,541
R01 · FY2022 · DK
Microbial Contributions to Arsenic Transformation in the Gut$287,557
P42 · FY2022 · ES · contact PI
Intestinal lysozyme controls mucosal immune response to microbiota$358,541
R01 · FY2021 · DK
Microbial Contributions to Arsenic Transformation in the Gut$287,557
P42 · FY2021 · ES · contact PI
Research Supplements to Promote Diversity in Health-Related Research$40,000
R01 · FY2021 · DK
Intestinal lysozyme controls mucosal immune response to microbiota$357,125
R01 · FY2020 · DK
Modulation of dendritic cell function in the pathogenesis of Inflammatory Bowel Diseases$345,375
R01 · FY2020 · DK · contact PI
Microbial Contributions to Arsenic Transformation in the Gut$316,087
P42 · FY2020 · ES · contact PI
Intestinal lysozyme controls mucosal immune response to microbiota$383,457
R01 · FY2019 · DK
Modulation of dendritic cell function in the pathogenesis of Inflammatory Bowel Diseases$345,375
R01 · FY2019 · DK · contact PI
Modulation of dendritic cell function in the pathogenesis of Inflammatory Bowel Diseases$345,375
R01 · FY2018 · DK · contact PI
Modulation of dendritic cell function in the pathogenesis of Inflammatory Bowel Diseases$345,375
R01 · FY2017 · DK · contact PI
Modulation of dendritic cell function in the pathogenesis of Inflammatory Bowel Diseases$345,375
R01 · FY2016 · DK · contact PI
Development of Intestinal Ion Transport$329,513
R01 · FY2016 · DK
Development of Intestinal Ion Transport$329,513
R01 · FY2015 · DK
Development of Intestinal Ion Transport$329,513
R01 · FY2014 · DK
Development of Intestinal Ion Transport$325,743
R01 · FY2013 · DK
Intestinal Barrier Function: Protective Effects of Curcumin$288,321
R01 · FY2013 · DK · contact PI
Development of Intestinal Ion Transport$329,513
R01 · FY2012 · DK
Intestinal Barrier Function: Protective Effects of Curcumin$298,778
R01 · FY2012 · DK · contact PI
Intestinal Barrier Function: Protective Effects of Curcumin$298,778
R01 · FY2011 · DK · contact PI
Intestinal Barrier Function: Protective Effects of Curcumin$377,245
R01 · FY2010 · DK · contact PI
Inflammatory Bowel Disease: A Novel Therapeutic Approach$266,592
R01 · FY2009 · DK · contact PI
Inflammatory Bowel Disease: A Novel Therapeutic Approach$266,592
R01 · FY2008 · DK · contact PI
Inflammatory Bowel Disease: A Novel Therapeutic Approach$272,033
R01 · FY2007 · DK · contact PI
Inflammatory Bowel Disease: A Novel Therapeutic Approach$279,771
R01 · FY2006 · DK · contact PI
Inflammatory Bowel Disease: A Novel Therapeutic Approach$285,950
R01 · FY2005 · DK